Changes in Histone H3 acetylation in panobinostat-treated IDH-wildtype and IDH-mutant glioma cultures
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 28 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Lower-grade gliomaThis series is part of our curated briefing on it.
- Samples
- 28 samples: 28 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE308631_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1331758 and SRA study SRP622540. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 28 sample titles: 28 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9249492 827 p10 Veh rep1
- GSM9249493 827 p10 Pano rep1
- GSM9249494 827 p9 Veh rep2
- GSM9249495 827 p9 Pano rep2
- GSM9249496 827 p7 Veh rep3
- GSM9249497 827 p7 Pano rep3
- GSM9249498 923 p11 Veh rep1
- GSM9249499 923 p11 Pano rep1
- GSM9249500 923 p9 Veh rep2
- GSM9249501 923 p9 Pano rep2
- GSM9249502 923 p7 Veh rep3
- GSM9249503 923 p7 Pano rep3
- GSM9249504 905 p9 Veh rep1
- GSM9249505 905 p9 Pano rep1
- GSM9249506 905 p13 Veh rep2
- GSM9249507 905 p13 Pano rep2
- GSM9249508 905 p8 Veh rep3
- GSM9249509 905 p8 Pano rep3
- GSM9249510 BT142 p14 Veh rep1
- GSM9249511 BT142 p14 Pano rep1
- GSM9249512 BT142 p13 Veh rep2
- GSM9249513 BT142 p13 Pano rep2
- GSM9249514 BT142 p12 Veh rep3
- GSM9249515 BT142 p12 Pano rep3
- GSM9249516 827 Pooled Input
- GSM9249517 923 Pooled Input
- GSM9249518 905 Pooled Input
- GSM9249519 BT142 Pooled Input
- GSE308634 Transcriptional changes mediated by the HDACi panobinostat in IDH-wildtype and IDH-mutant gliomas 54 samples same disease briefing · shares idh-wildtype, idh-mutant, changes, glioma
- GSE308636 Transcriptional changes mediated by the HDACi belinostat in IDH-mutant glioma cultures with YAP and TAZ overexpression 36 samples same disease briefing · shares idh-mutant, cultures, changes, glioma
- GSE326221 Acquired genetic and cell state changes in IDH-mutant glioma progression [snRNA-seq] 75 samples same disease briefing · shares idh-mutant, changes, glioma
- GSE260997 Mutant IDH inhibitors induce lineage differentiation in IDH-mutant Oligodendroglioma III 2458 samples same disease briefing · shares idh-mutant, glioma
- GSE226321 Multimodal integration of transcriptomics, proteomics and radiomics improves prediction of recurrence in patients with IDH-mutant Glioma 59 samples same disease briefing · shares idh-mutant, glioma
- GSE252245 Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib 24 samples same disease briefing · shares idh-mutant, glioma
- GSE292732 A pilot trial of perioperative IDH Inhibition in treatment-naïve IDH-mutant glioma 11 samples same disease briefing · shares idh-mutant, glioma
- GSE260928 Mutant IDH inhibitors induce lineage differentiation in IDH-mutant Oligodendroglioma I 10 samples same disease briefing · shares idh-mutant, glioma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.